198
Views
0
CrossRef citations to date
0
Altmetric
POLYCYSTIC OVARY SYNDROME

A novel biochemical marker -OKL38- with its apoptotic and antioxidant properties for the development of PCOS and its related clinical implications

, &
Pages 673-677 | Received 10 Apr 2019, Accepted 16 Jan 2020, Published online: 30 Jan 2020

References

  • Colonese F, Lagana AS, Colonese E, et al. The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic. Biomed Res Int. 2015;2015:1–11.
  • Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562–2569.
  • Homburg R, Amsterdam A. Polysystic ovary syndrome–loss of the apoptotic mechanism in the ovarian follicles?. J Endocrinol Invest. 1998;21(9):552–557.
  • Amsterdam A, Selvaraj N. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev. 1997;18:435–461.
  • Mason HD, Willis DS, Beard RW, et al. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab. 1994;79:1355–1360.
  • Pasqualotto EB, Agarwal A, Sharma RK, et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril. 2004;81(4):973–976.
  • Yildirim M, Turkyilmaz E, Neselioglu S, et al. Dynamic thiol-disulphide status in polycystic ovary syndrome and its association with the pathogenesis of the disease. Gynecol Obstet Invest. 2017;82(1):54–59.
  • Wang T, Xia D, Li N, et al. Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis. J Biol Chem. 2005;280(6):4374–4382.
  • Ong CK, Ng CY, Leong C, et al. Structural characterization of three novel rat OKL38 transcripts, their tissue distributions, and their regulation by human chorionic gonadotropin. Endocrinology. 2004;145(10):4763–4774.
  • Yao H, Li P, Venters BJ, et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem. 2008;283(29):20060–20068.
  • Schrottmaier WC, Oskolkova OV, Schabbauer G, et al. MicroRNA miR-320a modulates induction of HO-1, GCLM and OKL38 by oxidized phospholipids in endothelial cells. Atherosclerosis. 2014;235(1):1–8.
  • Romanoski CE, Che N, Yin F, et al. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res. 2011;109(5):27–41.
  • Huynh H, Ng CY, Ong CK, et al. Cloning and characterization of a novel pregnancy-induced growth inhibitor in mammary gland. Endocrinology. 2001;142(8):3607–3615.
  • Lee S, Birukov KG, Romanoski CE, et al. Role of phospholipid oxidation products in atherosclerosis. Circ Res. 2012;111(6):778–799.
  • Li R, Chen W, Yanes R, et al. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J Lipid Res. 2007;48(3):709–715.
  • Chapple SJ, Siow RC, Mann GE. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol. 2012;44(8):1315–1320.
  • Rotterdam ESHRE/ASRM- Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
  • Wiksten-Almstromer M, Hirschberg AL, Hagenfeldt K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand. 2008;87:1162–1168.
  • Fruzzetti F, Perini D, Lazzarini V, et al. Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(5):335–343.
  • Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83(6):376–389.
  • Tola EN, Koroglu ND, Yalcin SE, et al. The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females. Arch Gynecol Obstet. 2018;297(2):487–493.
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752.
  • D’Agostino RB, Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753.
  • Tola EN, Köroğlu N, Ergin M, et al. The role of follicular fluid thiol/disulphide homeostasis in polycystic ovary syndrome. Balkan Med J. 2018;35(4):306–310.
  • Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–257.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.